Catheter-Directed Intervention for High-Risk Acute Pulmonary Embolism in Chronic Kidney Disease
Abstract Body (Do not enter title and authors here): Background: Catheter-Directed Interventions (CDIs) for Acute Pulmonary Embolism (PE) have been present for years but their use is limited due to paucity of data especially in patients with chronic kidney disease (CKD). We aim to compare safety and efficacy of CDIs in CKD patients with high-risk PE.
Methods: Nationwide Readmissions Database (2016-2021) was used to identify CKD patients presenting with high-risk PE (HR-PE) (shock, pressor or mechanical circulatory support requirement). We included CKD stages 3 and above including end-stage kidney disease (ESKD). Patients who received systematic thrombolysis were excluded. Mahalanobis Distance Matching within the Propensity Score Caliper was used to match patient who received CDIs vs those who did not. Inverse Probability weighting (IPW) was utilized, and Pearson’s chi-squared test was applied to the PSM-2 matched cohorts to compare outcomes.
Results: Among 931,585 hospitalizations of CKD patients with HR-PE, 1,404 (0.2%) of the patients underwent CDI. After propensity matching (N: 718 in each group), patients receiving CDI had a significantly lower mortality (36.6% vs. 48.6%, aOR:0.61, p <0.001). However, bleeding complications including major bleeding (8.1% vs 3.9%, aOR:1.7, p: 0.001), thoraco-respiratory bleeding (5.7% vs 2.9%, aOR:1.6, p <0.001) was higher in patients receiving CDIs. No difference was observed the risk of intracerebral hemorrhage (p>0.05). Readmission rates were similar at 30-day, 90-day and 180-day intervals (p>0.05). From 2016-2021, mortality associated with HR-PE in CKD patients has slightly increased (49.1% to 49.5%, p: 0.024). There has been increasing use of mechanical thrombectomy (MT) over thrombolysis in recent years (0.02% to 0.09%, p-trend <0.01).
Conclusion: CDIs for HR-PE in CKD patients are associated with significant reduction in mortality at an expense of higher bleeding risk. Despite slight increase in the utilization of MT, mortality has not significantly decreased across the years.
Kumar, Manoj
( John H Stroger Jr Hospital
, Chicago
, Illinois
, United States
)
Ricciardi, Mark
( Endeavor Health Cardiovascular Institute
, Evanston
, Illinois
, United States
)
Arman, Qamar
( Endeavor Health Cardiovascular Institute
, Evanston
, Illinois
, United States
)
Ali, Shafaqat
( Louisiana State University
, Shreveport
, Louisiana
, United States
)
Jamshed, Aneeza
( John H Stroger Hospital of Cook County Health
, Islamabad
, Pakistan
)
Murthi, Mukunthan
( John H Stroger Jr Hospital
, Chicago
, Illinois
, United States
)
Kumar, Nomesh
( DMC-Wayne State University
, Detroit
, Michigan
, United States
)
Kumar, Sanjay
( ISMMS Queens, NYC
, Jamaica
, New York
, United States
)
Alraies, M Chadi
( Detroit Medical Center
, Detroit
, Michigan
, United States
)
Gomez Valencia, Javier
( Cook County Health
, OAK PARK
, Illinois
, United States
)
Author Disclosures:
Manoj Kumar:DO NOT have relevant financial relationships
| Mark Ricciardi:No Answer
| Qamar Arman:No Answer
| Shafaqat Ali:DO NOT have relevant financial relationships
| Aneeza Jamshed:DO NOT have relevant financial relationships
| Mukunthan Murthi:No Answer
| Nomesh Kumar:DO NOT have relevant financial relationships
| Sanjay Kumar:No Answer
| Rinkle Kumari:DO NOT have relevant financial relationships
| M Chadi Alraies:DO NOT have relevant financial relationships
| Javier Gomez Valencia:DO NOT have relevant financial relationships